Hi ohm, a few questions, and thanks for taking the
Post# of 148230
Do you like the primary endpoints that we've chosen?
Will 90 patients split into 3 groups (350, 700, and Placebo) be powered enough to show significance? I guess this trial isn't to get us approval so it may not be all that important here.
Based off of previous studies, do we have any idea what kind of outcome we can/should expect?